Medical Weight Loss for Brookings, South Dakota Residents

Brookings, South Dakota residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Brookings through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Honest pricing for Brookings patients: compounded semaglutide starts at $166 per month ($499 for the 90-day program) and tirzepatide from $233 per month, billed separately. No distance surcharge for South Dakota residents. Doctor review just $119 (medication separate).

Why Brookings Residents Choose New Hope Weight Loss

If past attempts left you frustrated, Brookings, the difference here is structure and honesty. There is a real physician, Dr. Anjmun Sharma, behind your plan, a transparent price you can see up front, and a program that meets you by telehealth instead of dragging you across South Dakota for every visit. Compounded semaglutide and tirzepatide are not magic and they are not FDA-approved, but paired with steady medical guidance they give a lot of people a genuine path forward.

Brookings residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Brookings address.

For anyone in Brookings, South Dakota, the distance to Costa Mesa simply does not matter, because Dr. Anjmun Sharma manages your entire program by video and message rather than in person. We care for patients throughout the greater Brookings area and eastern South Dakota. Follow-up check-ins are handled remotely, so adjusting your dose is simple whether you live near downtown Brookings or out toward the greater Brookings area and eastern South Dakota.

There are no local-office hours to fit your life around, so Brookings patients can meet Dr. Sharma on evenings or between work without crossing town. Your compounded semaglutide or tirzepatide ships directly to your Brookings address in an insulated cold-pack box, so it stays stable in transit. In a state as spread out as South Dakota, New Hope Weight Loss reaches patients by secure telehealth from our Costa Mesa, California clinic, so distance never stands in the way of care.

GLP-1 Weight Loss Programs Available

Semaglutide: the 90-Day Metabolic Reset

If you live in Brookings and want a clear starting point, this is it. Semaglutide, the active ingredient also used in Wegovy and Ozempic, costs from $166 per month or $499 for the 90-day program. Branded-drug trials showed roughly 15 to 17 percent average weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, so results vary.

Tirzepatide: the dual GLP-1 and GIP option

For patients who want a second lever, tirzepatide starts at $233 per month and acts on both GLP-1 and GIP receptors. Up to 22.5 percent body-weight loss appeared in branded-drug trials at qualifying doses, which is not typical. It shares an active ingredient with Mounjaro and Zepbound.

A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.

How Telehealth Works for Brookings

Here is how the whole thing works, start to finish, for anyone in Brookings.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Brookings address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Brookings

Is there somewhere in Brookings I can visit New Hope Weight Loss?

There is no physical office in Brookings. We work from a single clinic in Costa Mesa, California, and care for Brookings, South Dakota patients by telehealth. Your candidacy for a compounded GLP-1 plan is confirmed when Dr. Anjmun Sharma reviews your health information during an online video appointment.

Will Brookings patients have to make any in-person trips?

No trips are necessary. We provide care to Brookings completely through telehealth, covering consults, follow-up visits, and ongoing support remotely. Once Dr. Sharma signs off, your compounded semaglutide or tirzepatide is delivered to Brookings in cold-pack shipping that preserves the correct temperature.

What does the program cost a Brookings patient?

Budget $119 for the physician visit. Semaglutide is priced from $166 monthly or $499 for 90 days, and tirzepatide from $233 monthly. The medication is a separate line item. We accept HSA, FSA, Klarna, and Affirm, and no distance surcharge is added for patients located in Brookings.

What areas of Brookings do you serve?

We serve patients from across Brookings by telehealth, including the greater Brookings area and eastern South Dakota.

Are there hidden fees for Brookings patients?

No. Brookings patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.

Brookings Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Brookings, South Dakota by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.